The manufacturers of voriconazole predict that it may raise the levels of the sulphonylureas, and hypoglycaemia may result. Until more is known careful monitoring of blood glucose is advisable during concurrent use.
(11)
This site is intended for general information only. The information provided on this site does not constitute medical advice and should not be relied upon. You should not act or refrain from acting on any legal or medical matter based on the content of this site.